Neurosynaptic Communications Pvt. Ltd. (Neurosynaptic), the leader in Telehealth technologies has announced a strategic investment from e-Zest Solutions Ltd. (e-Zest), a global IT services organization focused on emerging technologies. e-Zest has invested in Neurosynaptic to accelerate the company's growth at a strategic time in the history of the company.
Neurosynaptic’s industry-leading ReMeDi™ product remains the clear market leader focused on TeleHealth market in the developing countries it has always served. ReMeDi™ is now largest Telehealth consulting technology platform in India with 1600 operational health centers. e-Zest’s strategic investment has positioned the Company to accelerate R&D and expansion of the product line allowing customers to derive more value from this mission critical solution.
“In e-Zest, Neurosynaptic has found a partner that will help the company to grow at an accelerated pace while preserving our commitment to customers, partners and the markets that have been responsible for our success from the start,” said Sameer Sawarkar, Chief Executive Officer, Neurosynaptic Communications. “e-Zest’s extensive software product engineering & healthcare industry experience makes them an ideal partner as we realize our growth and expansion plans.”
Neurosynaptic’s Board will be joined by senior software industry entrepreneur & e-Zest’s President Shrikant Shingane. Shrikant brings extensive experience with growing technology companies to Neurosynaptic and will focus on mentoring that will drive future growth of the company.
Unitus Capital was the sole advisor to Neurosynaptic for the transaction. “We are extremely thrilled to have partnered with Neurosynaptic in this critical transaction. We expect the strategic partnership between Neurosynaptic and e-Zest to be transformative for both companies and further revolutionize delivery of much needed healthcare services in India. Neurosynaptic is a leader in the Tele-Health domain and has done credulous work in India through their cutting edge technology solutions making healthcare both affordable and available in the excluded parts of the country; we are excited about the growth prospects for the sector and Neurosynaptic in the coming years.” stated Eric Savage, Co-Founder & President, Unitus Capital.
“We are really excited about being a partner in revolutionizing healthcare delivery using innovative technologies & business processes. By leveraging e-Zest’s expertise in Cloud, Mobile, UX & Analytics, our goal is to help ReMeDi™ become world leader in Tele-Health market” said Devendra Deshmukh, Chief Executive Officer, e-Zest.
“In addition to Devendra & Shrikant, we would like to thank Jaywant Deshpande, Co-founder, e-Zest, for helping to realize this partnership as well as Gerald Manohar, Partner at JSA for acting as our legal counsel and Sunil Nanal, Partner at ‘Kanj and Associates’ for advising e-Zest on the transaction. We would also like to thank Technology Development Board, Department of Science and Technology for their continuing support for Neurosynaptic” said Rajeev Kumar, Director, Neurosynaptic.
About Neurosynaptics (www.neurosynaptic.com):
(Neurosynaptic) is a technology-led innovation company and is the leader in TeleHealth domain in India. Its flagship platform, ReMeDi™ has revolutionized remote healthcare space in India with its 1600 deployments reaching 45 Million population. ReMeDi™ has been deployed at several locations across the globe, impacting healthcare in several developing countries. Neurosynaptic has earlier been selected for the prestigious Technology Pioneer Award by the World Economic Forum, Switzerland; the Global Indus Technovator Award by IBC, MIT, Boston, was chosen as the fastest growing social enterprise in the health category by the ‘Action For India’ Forum, Delhi, India.
